SD Biotechnologies Co., Ltd. Stock

Equities

A217480

KR7217480003

Personal Products

End-of-day quote Korea S.E. 07:00:00 2023-03-21 pm EDT 5-day change 1st Jan Change
500 KRW -4.90% Intraday chart for SD Biotechnologies Co., Ltd. +0.00% +0.00%
Sales 2022 92.86B 67.79M Sales 2023 46.94B 34.27M Capitalization 14.87B 10.86M
Net income 2022 -72.75B -53.11M Net income 2023 -4.61B -3.36M EV / Sales 2022 1.06 x
Net Debt 2022 45.7B 33.36M Net Debt 2023 3.49B 2.55M EV / Sales 2023 0.39 x
P/E ratio 2022
-0.46 x
P/E ratio 2023
-3.49 x
Employees 74
Yield 2022 *
-
Yield 2023
-
Free-Float 95.96%
More Fundamentals * Assessed data
Dynamic Chart
SD Biotechnologies Co., Ltd. cancelled the transaction announced on January 26, 2023 CI
SD Biotechnologies Co., Ltd. announced that it has received KRW 20 billion in funding from Sangsangin Investment & Securities Co.,Ltd. CI
SD Biotechnologies Co., Ltd. announced that it expects to receive KRW 11.999999918 billion in funding CI
SD Biotechnologies Co., Ltd. agreed to acquire a 38.636208% stake in IMMUNOBIOTECH Corp. from KOSSEN Co., Ltd. for KRW 5.3 billion. CI
SD Biotechnologies to Raise $27 Million From Share Sale; Shares Slump 23% MT
SD Biotechnologies Co., Ltd. Auditor Raises 'Going Concern' Doubt CI
SD Biotechnologies Co., Ltd. announced that it has received KRW 17 billion in funding from BNK Securities Co., Ltd. CI
SD Biotechnologies Co., Ltd. announced that it expects to receive KRW 17000 billion in funding from BNK Securities Co., Ltd. and other investors CI
SD Biotechnologies Co., Ltd. announced that it has received KRW 21 billion in funding from Leading Investment & Securities Co., Investment Arm, EBEST Investment & Securities Co., Ltd. CI
SD Biotechnologies Co., Ltd. announced that it expects to receive KRW 21 billion in funding from Leading Investment & Securities Co., Investment Arm, EBEST Investment & Securities Co., Ltd. CI
SD Biotechnologies Co., Ltd. cancelled the acquisition of remaining 5.59% stake in Alpha B&H Co.,Ltd. CI
SD Biotechnologies Co., Ltd. agreed to acquire remaining 5.59% stake in Alpha B&H Co.,Ltd for KRW 45.7 million. CI
SD Biotechnologies Co., Ltd. has completed an IPO in the amount of KRW 57.6 billion. CI
SD Biotechnologies Co., Ltd. has filed an IPO. CI
More news
1 day-4.90%
1 week+0.00%
Current month+0.00%
1 month+0.00%
3 months+0.00%
6 months+0.00%
Current year+0.00%
More quotes
3 years
494.27
Extreme 494.26769900
8 065.88
5 years
494.27
Extreme 494.26769900
14 899.66
10 years
494.27
Extreme 494.26769900
32 951.18
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 -
President 55 -
Comptroller/Controller/Auditor 64 -
Members of the board TitleAgeSince
Chief Executive Officer 61 -
Director/Board Member 64 -
President 55 -
More insiders
SD BIOTECHNOLOGIES CO., LTD. is a Korea-based company principally engaged in manufacture and distribution of cosmetics. The Company’s products include basic skin care products and mask pack. The Company distributes its products within the domestic market and to overseas markets
More about the company
  1. Stock Market
  2. Equities
  3. A217480 Stock